Category Archives: Original Articles

The Pandemic’s Sleeping Giant: The Vaccine

Written By: Hannah Saul

Through the seven long months that COVID-19 has run rampant in North America, we have seen many waves of supply and demand of varying degrees come and go. Through periods where politicians were urging us to buy hand sanitizers that were constantly sold out, to toilet paper becoming a hot commodity – leaving people to forget that tissues or a shower are probably perfect substitutes to Cottonelle or Charmin – this idea of scarcity has become a greater focus for many that have not yet experienced it in their lifetime.

Continue reading…

Data Creates Competitive Advantage – Probably Not Always.

Written By: Tanya Singh

Access to consumer data has brought about a focal change in the business environment, from small scale industries to tech giants, the synthesis of consumer information to make it relevant to the business operations, and the curation of products became a priority. Interestingly, the storage of data dates back to the 18,000 BCE, when the Palaeolithic tribespeople would mark notches into sticks or bones to keep a track of trading activities. Now, most firms use consumer data to create an unbeatable competitive advantage in the market – the more customers a firm has, the greater the data gathering process is.However, more often than not,firms grossly overestimate their ability to gain a competitive advantage through consumer data which we shall be talking about in detail. 

Continue reading…

The Ice Age in relations is here to stay: how US-China tensions are expanding from trade to everything.

Written By: Tanya Singh

The US-China trade relationship has expanded immensely after China’s reformation of its economy and liberalization in 1979.The world’s two largest economies have persevered bitter rivalry locked by a trade battle for a year now. The onset of the pandemic revealed new dynamics in the US-China trade wars, overshadowing the agreement made in January that was meant to draw President Trump’s policy still endeavours to encourage domestic production and purchases leading it to impose more than $360bn worth of tariffs on Chinese goods. According to the “phase one” deal signed in January, China vowed to boost US imports by $200bn above 2017 levels and extend intellectual property rules, however, Trump seems to have delayed the upliftment of tariffs and with the recent indictments regarding Covid-19, it seems that both the countries are back to square one. Here’s how we can break this situation down:

Continue reading…